International Journal of Cardiology
Volume 130, Issue 3 , Pages 374-379 , 28 November 2008

Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry

  • Bryan P. Yan

      Affiliations

    • Department of Cardiology of the Royal Melbourne Hospital, Australia
    • ,
  • Andrew E. Ajani

      Affiliations

    • Department of Cardiology of the Royal Melbourne Hospital, Australia
    • NHMRC Centre of Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    • University of Melbourne, Australia
    • ,
  • Gishel New

      Affiliations

    • Department of Cardiology of the Box Hill Hospital, Australia
    • ,
  • Stephen J. Duffy

      Affiliations

    • Department of Cardiology of the Alfred Hospital, Australia
    • ,
  • Omar Farouque

      Affiliations

    • Department of Cardiology of the Austin Hospital, Australia
    • University of Melbourne, Australia
    • ,
  • James Shaw

      Affiliations

    • Department of Cardiology of the Alfred Hospital, Australia
    • ,
  • Martin Sebastian

      Affiliations

    • Department of Cardiology of the Geelong Hospital, Australia
    • ,
  • Robert Lew

      Affiliations

    • Department of Cardiology of the Frankston Hospital, Australia
    • ,
  • Angela Brennan

      Affiliations

    • NHMRC Centre of Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    • ,
  • Nick Andrianopoulos

      Affiliations

    • NHMRC Centre of Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    • ,
  • Chris Reid

      Affiliations

    • NHMRC Centre of Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    • ,
  • David J. Clark

      Affiliations

    • Department of Cardiology of the Austin Hospital, Australia
    • University of Melbourne, Australia
    • Corresponding Author InformationCorresponding author. Department of Cardiology, Level 5, Austin Hospital, 145 Studley Road, Heidelberg, Victoria 3084, Australia. Tel.: +61 3 9496 5527; fax: +61 3 9459 0971.
    • ,
  • on behalf of Melbourne Interventional Group Investigators

Received 29 October 2007 ,Revised 11 June 2008 ,Accepted 28 June 2008.

References 

  1. Cutlip DE, Chauhan MS, Baim DS, et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol. 2002;40(12):2082–2089
  2. Elezi S, Kastrati A, Neumann FJ, et al. Vessel size and long-term outcome after coronary stent placement. Circulation. 1998;98(18):1875–1880
  3. Foley DP, Melkert R, Serruys PW. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation. 1994;90(3):1239–1251
  4. Mercado N, Boersma E, Wijns W, et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol. 2001;38(3):645–652
  5. Ellis SG, Bajzer CT, Bhatt DL, et al. Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularization. Catheter Cardiovasc Interv. 2004;63(2):135–140
  6. Eisenberg MJ, Konnyu KJ. Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis. Am J Cardiol. 2006;98(3):375–382
  7. Marzocchi A, Piovaccari G, Manari A, et al. Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events. Am J Cardiol. 2005;95(12):1409–1414
  8. Kaiser C, et al. BASKET Investigators Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET). Lancet. 2005;366(9489):921–929
  9. Stone GW, et al. TAXUS-IV Investigators A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221–231
  10. Stone GW, et al. TAXUS V Investigators Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005;294(10):1215–1223
  11. Fajadet J, et al. ENDEAVOR II Investigators Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation. 2006;114(8):798–806
  12. Pache J, Dibra A, Mehilli J, et al. Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial. Eur Heart J. 2005;26(13):1262–1268
  13. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369(9562):667–678
  14. Lagerqvist B, et al. SCAAR Study Group Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356(10):1009–1019
  15. Bhatt DL, et al. CHARISMA Investigators Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354(16):1706–1717
  16. Ajani AE, et al. Melbourne Interventional Group investigators The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project. Heart Lung Circ. 2006;15(1):44–47
  17. Yan BP, Ajani AE, Clark DJ, et al. Use of drug-eluting stents in Victorian public hospitals. Med J Aust. 2006;185(7):363–367
  18. Smith SC, Feldman TE, Hirshfeld JW, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006;113(1):156–175
  19. Cutlip DE, et al. Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344–2351
  20. Pache J, Kastrati A, Mehilli J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol. 2003;41(8):1283–1288
  21. Marroquin OC, Selzer F, Mulukutla SR, et al. Comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med. 2008;358(4):342–352
  22. Quizhpe AR, Feres F, de Ribamar Costa J, et al. Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels. Am Heart J. 2007;154(2):373–378
  23. Rocca HP, Kaiser C, Pfisterer M. Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET). Eur Heart J. 2007;28(6):719–725
  24. Moses JW, et al. SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315–1323
  25. Popma JJ, et al. SIRIUS Investigators Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation. 2004;110(25):3773–3780
  26. Lemos PA, Mercado N, van Domburg RT, et al. Comparison of late luminal loss response pattern after sirolimus-eluting stent implantation or conventional stenting. Circulation. 2004;110(20):3199–3205
  27. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356(10):998–1008
  28. Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356(10):1020–1029
  29. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356(10):1030–1039
  30. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126–2130
  31. Grines CL, Bonow RO, Casey DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Catheter Cardiovasc Interv. 2007;69(3):334–340
  32. Yan BP, Gurvitch R, Ajani AE. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation. Cardiovasc Revasc Med. 2006;7(3):155–158
  33. Cohen DJ, et al. SIRIUS Investigators Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation. 2004;110(5):508–514
  34. Mauri L, O'Malley AJ, Popma JJ, et al. Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents. Am J Cardiol. 2005;95(10):1140–1145
  35. Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006;113:1108–1113
  36. Moreno R, Fernandez C, Hernandez R, et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol. 2005;45:954

PII: S0167-5273(08)00845-0

doi: 10.1016/j.ijcard.2008.06.046

International Journal of Cardiology
Volume 130, Issue 3 , Pages 374-379 , 28 November 2008

Article Tools

* Image Usage & Resolution